Medical-device maker Misonix said it voluntarily contacted the Securities and Exchange Commission and the U.S. Department of Justice this week to inform them about potential violations of the Foreign Corrupt Practices Act.
“The company may have had knowledge of certain business practices of the independent Chinese entity that distributes its products in China,” Misonix said a Sept. 28 Form 8-K filing.
